Disclosure of the genetic risk of Alzheimer's disease.
نویسندگان
چکیده
Since publication of their article, the authors report no further potential conflict of interest. Fiore AE, Shay DK, Broder K, et al. Prevention and control 1. of inf luenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. Atlanta: Centers for Disease Control and Prevention. (Accessed December 21, 2009, at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr57e717a1 .htm.) Monto AS, Sullivan KM. Acute respiratory illness in the 2. community: frequency of illness and the agents involved. Epidemiol Infect 1993;110:145-60. Ohmit SE, Monto AS. Symptomatic predictors of influenza 3. virus positivity in children during the influenza season. Clin Infect Dis 2006;43:564-8.
منابع مشابه
The role of genetics in alzheimer’s disease
Alzheimer's disease is a progressive neurological disorder that causes the brain to shrink (atrophy) and brain cells die. Alzheimer's disease is the most common cause of dementia and causes a decrease in thinking skills and social behaviors. Alzheimer's disease is more common in people over 65 years old. The risk of developing Alzheimer's disease and other types of dementia increases with age,...
متن کاملThe recent development in synthesis and pharmacological evaluation of small molecule to treat Alzheimer's diseases: A review
Alzheimer's disease is a neurological disorder in which the death of brain cells causes memory loss and cognitive decline. A neurodegenerative type of dementia, the disease starts mild and gets progressively worse. Like all types of dementia, Alzheimer's is caused by brain cell death. The most common presentation marking Alzheimer's dementia is where symptoms of memory loss are the most promine...
متن کاملThe recent development in synthesis and pharmacological evaluation of small molecule to treat Alzheimer's diseases: A review
Alzheimer's disease is a neurological disorder in which the death of brain cells causes memory loss and cognitive decline. A neurodegenerative type of dementia, the disease starts mild and gets progressively worse. Like all types of dementia, Alzheimer's is caused by brain cell death. The most common presentation marking Alzheimer's dementia is where symptoms of memory loss are the most promine...
متن کاملA randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.
INTRODUCTION Conventional multisession genetic counseling is currently recommended when disclosing apolipoprotein E (APOE) genotype for the risk of Alzheimer's disease (AD) in cognitively normal individuals. The objective of this study was to evaluate the safety of brief disclosure protocols for disclosing APOE genotype for the risk of AD. METHODS A randomized, multicenter noninferiority tria...
متن کاملبررسی پلی مورفیسم ژن APOE در بیماران ایرانی مبتلا به آلزایمر
Background: Alzheimer's disease is a multi-factorial disorder. The genes involved in Alzheimer's disease act as risk factors. The aim of this study was to investigate the APOE gene polymorphism in patients with Alzheimer's disease in Iran. Materials and Methods: In this analytical-descriptive study, 50 patients with Alzheimer's were investigated. Polymorphism of the APOE gene was investigated ...
متن کاملDisclosure of APOE genotype for risk of Alzheimer's disease.
BACKGROUND The apolipoprotein E (APOE) genotype provides information on the risk of Alzheimer's disease, but the genotyping of patients and their family members has been discouraged. We examined the effect of genotype disclosure in a prospective, randomized, controlled trial. METHODS We randomly assigned 162 asymptomatic adults who had a parent with Alzheimer's disease to receive the results ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The New England journal of medicine
دوره 362 2 شماره
صفحات -
تاریخ انتشار 2010